Matthew D. Gallovic

1.1k total citations
23 papers, 906 citations indexed

About

Matthew D. Gallovic is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Matthew D. Gallovic has authored 23 papers receiving a total of 906 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Epidemiology and 8 papers in Immunology. Recurrent topics in Matthew D. Gallovic's work include RNA Interference and Gene Delivery (7 papers), Advanced Drug Delivery Systems (7 papers) and interferon and immune responses (5 papers). Matthew D. Gallovic is often cited by papers focused on RNA Interference and Gene Delivery (7 papers), Advanced Drug Delivery Systems (7 papers) and interferon and immune responses (5 papers). Matthew D. Gallovic collaborates with scholars based in United States. Matthew D. Gallovic's co-authors include Eric M. Bachelder, Kristy M. Ainslie, Michael A. Collier, Jenny P.‐Y. Ting, Naihan Chen, Robert D. Junkins, Cole J. Batty, Sadhana Sharma, Monica M. Johnson and Gregory D. Sempowski and has published in prestigious journals such as The Journal of Immunology, Biomaterials and Langmuir.

In The Last Decade

Matthew D. Gallovic

23 papers receiving 903 citations

Peers

Countries citing papers authored by Matthew D. Gallovic

Since Specialization

Citations

This map shows the geographic impact of Matthew D. Gallovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew D. Gallovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew D. Gallovic more than expected).

Fields of papers citing papers by Matthew D. Gallovic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew D. Gallovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew D. Gallovic. The network helps show where Matthew D. Gallovic may publish in the future.

Co-authorship network of co-authors of Matthew D. Gallovic

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew D. Gallovic. A scholar is included among the top collaborators of Matthew D. Gallovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew D. Gallovic. Matthew D. Gallovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A predictive mechanistic model of drug release from surface eroding polymeric nanoparticles 2022 ·Journal of Controlled Release ·(unknown), (unknown), (unknown), Matthew D. Gallovic, Liubov M. Lifshits, Christopher J. Genito, Eric M. Bachelder, Kristy M. Ainslie	45
2	STING agonist-containing microparticles improve seasonal influenza vaccine efficacy and durability in ferrets over standard adjuvant 2022 ·Journal of Controlled Release ·Matthew D. Gallovic, Robert D. Junkins, Adam Sandor, (unknown), Christopher Sample, (unknown), (unknown), (unknown), Eric M. Bachelder, Kristy M. Ainslie, Gregory D. Sempowski, Jenny P.‐Y. Ting	20
3	Multiplexed electrospray enables high throughput production of cGAMP microparticles to serve as an adjuvant for a broadly acting influenza vaccine 2022 ·International Journal of Pharmaceutics ·Cole J. Batty, Matthew D. Gallovic, Jonathan W. Williams, Ted M. Ross, Eric M. Bachelder, Kristy M. Ainslie	11
4	STING Agonist Mitigates Experimental Autoimmune Encephalomyelitis by Stimulating Type I IFN–Dependent and –Independent Immune-Regulatory Pathways 2021 ·The Journal of Immunology ·Brandon M. Johnson, (unknown), Matthew D. Gallovic, Madhan Thamilarasan, Wei-Chun Chou, Sara A. Gibson, Meng Deng, Jason W. Tam, Cole J. Batty, Jonathan W. Williams, Glenn K. Matsushima, Eric M. Bachelder, Kristy M. Ainslie, Silva Markovic‐Plese, Jenny P.‐Y. Ting	22
5	Electrospray for generation of drug delivery and vaccine particles applied in vitro and in vivo 2019 ·Materials Science and Engineering C ·(unknown), Matthew D. Gallovic, Cole J. Batty, Eric M. Bachelder, Kristy M. Ainslie	67
6	A microparticle platform for STING-targeted immunotherapy enhances natural killer cell- and CD8+ T cell-mediated anti-tumor immunity 2019 ·Biomaterials ·(unknown), (unknown), Matthew D. Gallovic, Robert D. Junkins, Cole J. Batty, Eric M. Bachelder, Kristy M. Ainslie, Jenny P.‐Y. Ting	78
7	In Vivo and Cellular Trafficking of Acetalated Dextran Microparticles for Delivery of a Host-Directed Therapy for Salmonella enterica Serovar Typhi Infection 2018 ·Molecular Pharmaceutics ·Monica M. Johnson, Michael A. Collier, Ky V. Hoang, (unknown), Elizabeth G. Graham-Gurysh, Matthew D. Gallovic, (unknown), Naihan Chen, Larry S. Schlesinger, John S. Gunn, Eric M. Bachelder, Kristy M. Ainslie	17
8	Acetalated Dextran Microparticles for Codelivery of STING and TLR7/8 Agonists 2018 ·Molecular Pharmaceutics ·Michael A. Collier, Robert D. Junkins, Matthew D. Gallovic, Brandon M. Johnson, Monica M. Johnson, Andrew N. Macintyre, Gregory D. Sempowski, Eric M. Bachelder, Jenny P.-Y. Ting, Kristy M. Ainslie	68
9	Tunable degradation of acetalated dextran microparticles enables controlled vaccine adjuvant and antigen delivery to modulate adaptive immune responses 2018 ·Journal of Controlled Release ·Naihan Chen, Monica M. Johnson, Michael A. Collier, Matthew D. Gallovic, Eric M. Bachelder, Kristy M. Ainslie	71
10	Investigation of tunable acetalated dextran microparticle platform to optimize M2e-based influenza vaccine efficacy 2018 ·Journal of Controlled Release ·Naihan Chen, Matthew D. Gallovic, (unknown), Jenny P.‐Y. Ting, Kristy M. Ainslie, Eric M. Bachelder	61
11	Injectable long-acting human immunodeficiency virus antiretroviral prodrugs with improved pharmacokinetic profiles 2018 ·International Journal of Pharmaceutics ·Sai Archana Krovi, Matthew D. Gallovic, (unknown), Menakshi Bhat, (unknown), Naihan Chen, Michael A. Collier, Elizabeth G. Graham-Gurysh, (unknown), Monica M. Johnson, Muhammad Zahid, Mackenzie L. Cottrell, Jason R. Pirone, Angela D. M. Kashuba, Jesse J. Kwiek, Eric M. Bachelder, Kristy M. Ainslie	7
12	A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination 2017 ·Journal of Controlled Release ·Robert D. Junkins, Matthew D. Gallovic, Brandon M. Johnson, Michael A. Collier, (unknown), Ning Cheng, Clément N. David, Charles E. McGee, Gregory D. Sempowski, Ivo Shterev, Karen P. McKinnon, Eric M. Bachelder, Kristy M. Ainslie, Jenny P.‐Y. Ting	125
13	A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination 2017 ·The Journal of Immunology ·Robert D. Junkins, Brandon M. Johnson, Matthew D. Gallovic, Michael A. Collier, (unknown), (unknown), Clément N. David, Charles E. McGee, Gregory D. Sempowski, Ivo Shterev, Karen P. McKinnon, Eric M. Bachelder, Kristy M. Ainslie, Jenny P.‐Y. Ting	4
14	Saquinavir Loaded Acetalated Dextran Microconfetti – a Long Acting Protease Inhibitor Injectable 2016 ·Pharmaceutical Research ·Michael A. Collier, Matthew D. Gallovic, Eric M. Bachelder, (unknown), Angela D. M. Kashuba, Kristy M. Ainslie	13
15	Degradation of acetalated dextran can be broadly tuned based on cyclic acetal coverage and molecular weight 2016 ·International Journal of Pharmaceutics ·Naihan Chen, Michael A. Collier, Matthew D. Gallovic, (unknown), (unknown), (unknown), Eric M. Bachelder, Kristy M. Ainslie	38
16	Acetalated Dextran Microparticulate Vaccine Formulated via Coaxial Electrospray Preserves Toxin Neutralization and Enhances Murine Survival Following Inhalational Bacillus Anthracis Exposure 2016 ·Advanced Healthcare Materials ·Matthew D. Gallovic, Kevin L. Schully, (unknown), (unknown), John R. Palmer, (unknown), Eric M. Bachelder, Barbara E. Wyslouzil, Andrea Keane‐Myers, Kristy M. Ainslie	46
17	Evaluation of a biodegradable microparticulate polymer as a carrier for Burkholderia pseudomallei subunit vaccines in a mouse model of melioidosis 2015 ·International Journal of Pharmaceutics ·Kevin L. Schully, (unknown), Angela M. Prouty, Matthew D. Gallovic, Shalini Gautam, Kevin J. Peine, Sadhana Sharma, Eric M. Bachelder, John Pesce, (unknown), Kristy M. Ainslie, Andrea Keane‐Myers	19
18	Electrospun Acetalated Dextran Scaffolds for Temporal Release of Therapeutics 2013 ·Langmuir ·(unknown), Matthew D. Gallovic, Sadhana Sharma, Kevin J. Peine, (unknown), Deanna J. Brackman, K. Gregg, Yanyi Xu, Xiaolei Guo, Jianjun Guan, Eric M. Bachelder, Kristy M. Ainslie	29
19	Rapid Vaccination Using an Acetalated Dextran Microparticulate Subunit Vaccine Confers Protection Against Triplicate Challenge by Bacillus Anthracis 2013 ·Pharmaceutical Research ·Kevin L. Schully, Sadhana Sharma, Kevin J. Peine, John Pesce, (unknown), (unknown), Angela M. Prouty, (unknown), (unknown), Matthew D. Gallovic, Eric M. Bachelder, Andrea Keane‐Myers, Kristy M. Ainslie	28
20	Delivery of host cell-directed therapeutics for intracellular pathogen clearance 2013 ·Expert Review of Anti-infective Therapy ·Michael A. Collier, Matthew D. Gallovic, Kevin J. Peine, (unknown), Eric M. Bachelder, John S. Gunn, Larry S. Schlesinger, Kristy M. Ainslie	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact